Nasopharyngeal carcinoma secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
Secondary prevention measures of nasopharyneal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers by routine TSH measurement is recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.
Secondary prevention measures of nasopharyneal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.
 
==Secondary Prevention==
==Secondary Prevention==
===Follow up after treatment===
===Follow up after treatment===

Revision as of 15:48, 29 September 2015

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma secondary prevention

CDC on Nasopharyngeal carcinoma secondary prevention

Nasopharyngeal carcinoma secondary prevention in the news

Blogs on Nasopharyngeal carcinoma secondary prevention

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Secondary prevention measures of nasopharyneal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.

Secondary Prevention

Follow up after treatment

Patients treated for nasopharyngeal carcinoma should follow-up for secondary prevention. Follow-up measures are shown in the table below:[1]

Follow up Description
Physical exam
  • Every 1-3 months for 1st year after treatment
  • Every 2-6 months for 2nd year after treatment
  • Every 4-8 months between 3 and 5 years after treatment
  • Annually thereafter
Nasendoscopy
  • Immediately after radiation therapy
Scanning
  • CT Scan
  • MRI

Scans are performed at routine intervals as follows:

  • Baseline scanning is done in 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient
  • Scanning for asymptomatic patients is not encouraged
Thyroid hormone testing
  • Thyroid stimulating hormone testing every 12 months if neck is exposed to radiation therapy
Dental screening
  • Only recommended if oral cavity is exposed to radiations

Table adapted from Pfister DG, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(8):917-23.[1]

References

  1. 1.0 1.1 Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.


Template:WikiDoc Sources